First Time Loading...
S

Shanghai Haishun New Pharmaceutical Packaging Co Ltd
SZSE:300501

Watchlist Manager
Shanghai Haishun New Pharmaceutical Packaging Co Ltd
SZSE:300501
Watchlist
Price: 12.48 CNY -2.35% Market Closed
Updated: May 12, 2024

Shanghai Haishun New Pharmaceutical Packaging Co Ltd
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Shanghai Haishun New Pharmaceutical Packaging Co Ltd
Cost of Revenue Peer Comparison

Comparables:
C
1378
600219
A
601600
000807
002532

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
S
Shanghai Haishun New Pharmaceutical Packaging Co Ltd
SZSE:300501
Cost of Revenue
-¥762.6m
CAGR 3-Years
-19%
CAGR 5-Years
-20%
CAGR 10-Years
N/A
C
China Hongqiao Group Ltd
HKEX:1378
Cost of Revenue
-¥112.8B
CAGR 3-Years
-19%
CAGR 5-Years
-9%
CAGR 10-Years
N/A
Shandong Nanshan Aluminium Co Ltd
SSE:600219
Cost of Revenue
-¥23B
CAGR 3-Years
-11%
CAGR 5-Years
-7%
CAGR 10-Years
-6%
A
Aluminum Corporation of China Ltd
SSE:601600
Cost of Revenue
-¥197.1B
CAGR 3-Years
-5%
CAGR 5-Years
-3%
CAGR 10-Years
-2%
Yunnan Aluminium Co Ltd
SZSE:000807
Cost of Revenue
-¥36B
CAGR 3-Years
-12%
CAGR 5-Years
-12%
CAGR 10-Years
-10%
Tianshan Aluminum Group Co Ltd
SZSE:002532
Cost of Revenue
-¥24.8B
CAGR 3-Years
6%
CAGR 5-Years
-87%
CAGR 10-Years
-40%

See Also

What is Shanghai Haishun New Pharmaceutical Packaging Co Ltd's Cost of Revenue?
Cost of Revenue
-762.6m CNY

Based on the financial report for Sep 30, 2023, Shanghai Haishun New Pharmaceutical Packaging Co Ltd's Cost of Revenue amounts to -762.6m CNY.

What is Shanghai Haishun New Pharmaceutical Packaging Co Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-20%

Over the last year, the Cost of Revenue growth was -10%. The average annual Cost of Revenue growth rates for Shanghai Haishun New Pharmaceutical Packaging Co Ltd have been -19% over the past three years , -20% over the past five years .